Gerwing, M.; Krähling, T.; Schliemann, C.; Harrach, S.; Schwöppe, C.; Berdel, A.F.; Klein, S.; Hartmann, W.; Wardelmann, E.; Heindel, W.L.;
et al. Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease. Cancers 2021, 13, 5880.
https://doi.org/10.3390/cancers13235880
AMA Style
Gerwing M, Krähling T, Schliemann C, Harrach S, Schwöppe C, Berdel AF, Klein S, Hartmann W, Wardelmann E, Heindel WL,
et al. Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease. Cancers. 2021; 13(23):5880.
https://doi.org/10.3390/cancers13235880
Chicago/Turabian Style
Gerwing, Mirjam, Tobias Krähling, Christoph Schliemann, Saliha Harrach, Christian Schwöppe, Andrew F. Berdel, Sebastian Klein, Wolfgang Hartmann, Eva Wardelmann, Walter L. Heindel,
and et al. 2021. "Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease" Cancers 13, no. 23: 5880.
https://doi.org/10.3390/cancers13235880
APA Style
Gerwing, M., Krähling, T., Schliemann, C., Harrach, S., Schwöppe, C., Berdel, A. F., Klein, S., Hartmann, W., Wardelmann, E., Heindel, W. L., Lenz, G., Berdel, W. E., & Wildgruber, M.
(2021). Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease. Cancers, 13(23), 5880.
https://doi.org/10.3390/cancers13235880